Cargando…

Universal Screening for Hepatitis C Virus in the ED Using a Best Practice Advisory

INTRODUCTION: In 2019 the United States Preventive Services Task Force (USPSTF) released draft guidelines recommending universal hepatitis C virus (HCV) screening for individuals aged 18–79. We aimed to assess the efficacy of an emergency department-based HCV screening program, by comparing screenin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ford, James S., Chechi, Tasleem, Toosi, Kavian, Mahmood, Bilawal, Meehleis, Dillon, Otmar, Michella, Tran, Nam, May, Larissa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Department of Emergency Medicine, University of California, Irvine School of Medicine 2021
Materias:	Population Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203013/ https://www.ncbi.nlm.nih.gov/pubmed/34125052 http://dx.doi.org/10.5811/westjem.2021.1.49667

Ejemplares similares

1292. Integrating HIV and Hepatitis C Screening in a High-Risk Emergency Department Population
por: Chechi, Tasleem, et al.
Publicado: (2019)

Comparing Hepatitis C Virus Screening in Clinics Versus the Emergency Department
por: Hluhanich, Rebecca, et al.
Publicado: (2022)

433. Implementation of an Emergency Department Syphilis Screening Program
por: Chechi, Tasleem, et al.
Publicado: (2019)

Data Resource: Children and Family Court Advisory and Support Service (Cafcass) public family law administrative records in England
por: Bedston, SJ, et al.
Publicado: (2020)

Guidance for researchers wanting to link NHS data using non-consent approaches: a thematic analysis of feedback from the Health Research Authority Confidentiality Advisory Group
por: Cross, Lauren, et al.
Publicado: (2020)

317. Utility of a Hepatitis C Screening Best Practice Advisory in University-based Primary Care Practices
por: Donaghey, Faith, et al.
Publicado: (2019)

The population bomb /
por: Ehrlich, Paul R.
Publicado: (1995)

Stakeholder bias in best practice advisories: an ethical perspective
por: Baird, Aaron, et al.
Publicado: (2020)

Hydroxychloroquine use in COVID-19: is the risk of cardiovascular toxicity justified?
por: Stevenson, Alex, et al.
Publicado: (2020)

Pharmacokinetics of Ipatasertib in Subjects With Hepatic Impairment Using 2 Methods of Classification of Hepatic Function
por: Sane, Rucha, et al.
Publicado: (2021)

Effect of Hepatic Impairment on Eluxadoline Pharmacokinetics
por: Marbury, Thomas C., et al.
Publicado: (2017)

Pharmacokinetics of Nintedanib in Subjects With Hepatic Impairment
por: Marzin, Kristell, et al.
Publicado: (2017)

Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib
por: Morcos, Peter N., et al.
Publicado: (2018)

Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment
por: Hoover, Randall, et al.
Publicado: (2016)

Characterization of the Effect of Hepatic Impairment on Upadacitinib Pharmacokinetics
por: Trueman, Sheryl, et al.
Publicado: (2019)

Effects of Hepatic Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites
por: Wang, Ellen Q., et al.
Publicado: (2021)

Pharmacokinetics, Safety, and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
por: Bækdal, Tine A., et al.
Publicado: (2018)

The Effect of Hepatic Impairment on the Pharmacokinetics of Intravenously Administered Felcisetrag (TAK‐954)
por: Czerniak, Richard, et al.
Publicado: (2022)

Pharmacokinetics of the Dual Melatonin Receptor Agonist Tasimelteon in Subjects With Hepatic or Renal Impairment
por: Torres, Rosarelis, et al.
Publicado: (2015)

Evaluation of the Pharmacokinetics and Safety of a Single Dose of Acalabrutinib in Subjects With Hepatic Impairment
por: Xu, Yan, et al.
Publicado: (2022)

Prevalence and Impact of Dysmenorrhea Among University Students in Ireland
por: Durand, Hannah, et al.
Publicado: (2021)

Single‐Center Evaluation of the Pharmacokinetics and Safety of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Mild to Moderate Hepatic Impairment
por: Dudkowski, Caroline, et al.
Publicado: (2017)

180. Best Practice Advisory Decreases Inpatient Urine Culture Orders
por: Skinner, Alisha, et al.
Publicado: (2018)

30718 Evaluating and advancing the CTSA external advisory board: Best practices
por: Kotarba, Joseph A., et al.
Publicado: (2021)

The impact of a best practice advisory on inpatient prescribing of piperacillin-tazobactam
por: Peterson, Katherine L., et al.
Publicado: (2022)

Maribavir Pharmacokinetics and Safety in Participants With Moderate Hepatic Impairment: A Phase 1, Open‐Label, Single‐Dose, Parallel Group Study
por: Song, Ivy, et al.
Publicado: (2022)

Evaluation of Evolocumab (AMG 145), a Fully Human Anti‐PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic Impairment
por: Gibbs, John P., et al.
Publicado: (2016)

Effect of Mild and Moderate Hepatic Impairment (Defined by Child–Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics
por: Zahir, Hamim, et al.
Publicado: (2022)

Pharmacokinetics of a Single Oral Dose of the MEK1/2 Inhibitor Selumetinib in Subjects With End‐Stage Renal Disease or Varying Degrees of Hepatic Impairment Compared With Healthy Subjects
por: Dymond, Angela W., et al.
Publicado: (2016)

Childbirth-Related Hospital Burden by Socioeconomic Status in a Universal Health Care Setting
por: Mah, Sarah Meghan, et al.
Publicado: (2018)

Parental behaviour of a precocial species: implications for juvenile survival
por: Dreitz, Victoria J.
Publicado: (2009)

A Profile of the SAIL Databank on the UK Secure Research Platform
por: Jones, KH, et al.
Publicado: (2019)

Filmed Monologue Vignettes: a novel method for investigating how clinicians document consultations in electronic health records
por: Glew, Simon, et al.
Publicado: (2018)

Exploring barriers and solutions in advancing cross-centre population data science
por: Jones, KH, et al.
Publicado: (2019)

Community Advisory Boards in Community-Based Participatory Research: A Synthesis of Best Processes
por: Newman, Susan D., et al.
Publicado: (2011)

National Immunization Therapeutic Advisory Group: it is time for experience sharing and best practice learning
por: Ricciardi, Walter, et al.
Publicado: (2015)

Public involvement & engagement in the work of a data safe haven: a case study of the SAIL Databank
por: Jones, Kerina H, et al.
Publicado: (2020)

Defining a study population using enhanced reporting of Aboriginality and the effects on study outcomes
por: McInerney, C, et al.
Publicado: (2020)

Claims-based measures of continuity of care have non-linear associations with health: data linkage study
por: Tran, Bich, et al.
Publicado: (2018)

Disease effects on reproduction can cause population cycles in seasonal environments
por: Smith, Matthew J, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_vtue0aiemcl9naum4kecnmgdb0